These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20699352)

  • 41. Event-related potentials in adults with Attention-Deficit/Hyperactivity Disorder: an investigation using an inter-modal auditory/visual oddball task.
    Barry RJ; Clarke AR; McCarthy R; Selikowitz M; Brown CR; Heaven PC
    Int J Psychophysiol; 2009 Feb; 71(2):124-31. PubMed ID: 19022305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of bupropion, nomifensine and dexamphetamine on performance, subjective feelings, autonomic variables and electroencephalogram in healthy volunteers.
    Hamilton MJ; Smith PR; Peck AW
    Br J Clin Pharmacol; 1983 Mar; 15(3):367-74. PubMed ID: 6405773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholinergic modulation of auditory P3 event-related potentials as indexed by CHRNA4 and CHRNA7 genotype variation in healthy volunteers.
    Hyde M; Choueiry J; Smith D; de la Salle S; Nelson R; Impey D; Baddeley A; Aidelbaum R; Millar A; Knott V
    Neurosci Lett; 2016 Jun; 623():36-41. PubMed ID: 27109789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of progressive reduction in P3 amplitude after the first-episode of schizophrenia: A 6-year follow-up study.
    Devrim-Üçok M; Keskin-Ergen Y; Üçok A
    Psychiatry Res; 2016 Sep; 243():303-11. PubMed ID: 27428084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dexamphetamine widens temporal and spatial binding windows in healthy participants.
    Kassim FM; Lahooti SK; Keay EA; Iyyalol R; Rodger J; Albrecht MA; Martin-Iverson MT
    J Psychiatry Neurosci; 2023; 48(2):E90-E98. PubMed ID: 36918195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.
    Lee H; Wang GY; Curley LE; Kydd RR; Kirk IJ; Russell BR
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2869-77. PubMed ID: 27289365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association Study between Auditory P3a/P3b Event-Related Potentials and Thought Disorder in Schizophrenia.
    Kirihara K; Araki T; Uetsuki M; Yamasue H; Hata A; Rogers MA; Iwanami A; Kasai K
    Brain Imaging Behav; 2009 Sep; 3(3):277-83. PubMed ID: 22005990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reinstating the Novelty P3.
    Barry RJ; Steiner GZ; De Blasio FM
    Sci Rep; 2016 Aug; 6():31200. PubMed ID: 27510599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects.
    Peck AW; Bye CE; Clubley M; Henson T; Riddington C
    Br J Clin Pharmacol; 1979 May; 7(5):469-78. PubMed ID: 475943
    [No Abstract]   [Full Text] [Related]  

  • 50. Policosanol, reaction time and event-related potentials.
    Fontani G; Maffei D; Lodi L
    Neuropsychobiology; 2000; 41(3):158-65. PubMed ID: 10754431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests.
    Bye C; Munro-Faure AD; Peck AW; Young PA
    Eur J Clin Pharmacol; 1973 Oct; 6(3):163-9. PubMed ID: 4762054
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts.
    Campbell H; Cline W; Evans M; Lloyd J; Peck AW
    Eur J Clin Pharmacol; 1973 Oct; 6(3):170-6. PubMed ID: 4586849
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of dextroamphetamine on psychomotor skills.
    Evans MA; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Jun; 19(6):777-81. PubMed ID: 1269217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DEXAMPHETAMINE COMPARED WITH AN INACTIVE PLACEBO IN DEPRESSION.
    O'DONNELL M
    Practitioner; 1964 Jan; 192():151-4. PubMed ID: 14106646
    [No Abstract]   [Full Text] [Related]  

  • 55. A Double-Blind, Study To Assess the Effects of Single Oral Doses of Lorazepam On the Auditory P3 Evoked Response: Fell GL, Huckle KE. Link CGG, Semple JM. Clinical Pharmacology Unit, SmithKline Beecham Pharmaceuticals, Research Division, Medicinal Research Centre, Coldharbour Road, The Pinnacles, Harlow, Essex, CM19 SAD.
    J Psychopharmacol; 1992 Jan; 6(1):129. PubMed ID: 22291309
    [No Abstract]   [Full Text] [Related]  

  • 56. Reduced psychoacoustic sensitivity to auditory temporal stimulation in schizophrenia reflects cytoarchitecturally specific changes in auditory cortex.
    Budd B
    Acta Neuropsychiatr; 2006 Dec; 18(6):244. PubMed ID: 27397167
    [No Abstract]   [Full Text] [Related]  

  • 57. Dexamphetamine reduces auditory P3 delta power and phase-locking while increasing gamma power.
    Albrecht MA; Price G; Lee J; Iyyalol R; Martin-Iverson MT
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):734-46. PubMed ID: 22440975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development, Insults and Predisposing Factors of the Brain's Predictive Coding System to Chronic Perceptual Disorders-A Life-Course Examination.
    Yasoda-Mohan A; Vanneste S
    Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38248301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cortico-cortical connectivity behind acoustic information transfer to mouse orbitofrontal cortex is sensitive to neuromodulation and displays local sensory gating: relevance in disorders with auditory hallucinations?
    Tripathi A; Sato SS; Medini P
    J Psychiatry Neurosci; 2021 May; 46(3):E371-E387. PubMed ID: 34043305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.
    Bravermanová A; Viktorinová M; Tylš F; Novák T; Androvičová R; Korčák J; Horáček J; Balíková M; Griškova-Bulanova I; Danielová D; Vlček P; Mohr P; Brunovský M; Koudelka V; Páleníček T
    Psychopharmacology (Berl); 2018 Feb; 235(2):491-503. PubMed ID: 29302713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.